Insurtech earns top marks in strategy and current offering categories MILWAUKEE, Dec. 15, 2025 /PRNewswire/ — Leading insurtech provider, Zywave, announced today that it has been recognized as a leader by Forrester Research in The Forrester Wave™: Insurance Agency Management Systems, Q4 2025. According to the report, “Zywave’s SaaS platform offers agencies a robust marketing toolkit, quoting and proposal… Continue reading Zywave Named as a Leader in Insurance Agency Management Systems
Tag: Financial Results
Highmark Health Reports $24.6 Billion in Revenue, $69 Million Net Loss for the Nine Months ended Sept. 30, 2025; Maintains Growth Posture Amid Continuing Industry Challenges
Allegheny Health Network reports 11% revenue growth, $79 million operating income, a $167 million improvement year over year Highmark Health Plans reports 13% revenue growth, $211 million operating loss Diversified businesses report 7% revenue growth, $29 million consolidated operating income Highmark Inc., AHN announce strategic affiliations expected to take effect in 2026, pending regulatory approvals… Continue reading Highmark Health Reports $24.6 Billion in Revenue, $69 Million Net Loss for the Nine Months ended Sept. 30, 2025; Maintains Growth Posture Amid Continuing Industry Challenges
Dental Laboratories Market worth $13.09 billion by 2030 | MarketsandMarkets™
DELRAY BEACH, Fla., Dec. 15, 2025 /PRNewswire/ — According to MarketsandMarkets™, the Dental Laboratories Market is projected to grow from about USD 9.20 billion in 2025 to USD 13.09 billion by 2030, at a CAGR of 7.3%. Browse 260 market data Tables and 65 Figures spread through 330 Pages and in-depth TOC on ‘Dental Laboratories… Continue reading Dental Laboratories Market worth $13.09 billion by 2030 | MarketsandMarkets™
JamLoop Appoints Jeff Fagel as Chief Marketing Officer, Names Oksana Korsakova Chief Operating Officer
CTV-first technology platform expands leadership team to meet rising demand for performance TV advertising across local and national advertisers WALNUT CREEK, Calif., Dec. 15, 2025 /PRNewswire/ — JamLoop, a CTV-first technology platform bringing performance advertising to streaming TV, announced today that veteran marketing leader Jeff Fagel has joined the company as Chief Marketing Officer. Additionally, Oksana… Continue reading JamLoop Appoints Jeff Fagel as Chief Marketing Officer, Names Oksana Korsakova Chief Operating Officer
Premiere Northern Virginia Medspa Introduces Expanded Advanced Aesthetic Offerings in the Heart of Tysons
TYSONS CORNER, Va., Dec. 15, 2025 /PRNewswire/ — Maia Medspa, part of Maia Plastic Surgery and led by Board Certified Plastic Surgeon Dr. Munique Maia, announces the expansion of its advanced aesthetic technology and regenerative offerings. Located in the heart of Tysons Corner, the medspa now provides a comprehensive range of laser, light, and skin… Continue reading Premiere Northern Virginia Medspa Introduces Expanded Advanced Aesthetic Offerings in the Heart of Tysons
Fondazione Telethon and Orphan Therapeutics Accelerator Sign Memorandum of Understanding to Pioneer Non-Profit Commercial Access Model for Ultra-Rare Disease Gene Therapy in the US
The MoU establishes the foundation for a distribution and access agreement under which Orphan Therapies, a non-profit subsidiary of Orphan Therapeutics Accelerator (OTXL), would become the exclusive commercialization partner for the therapy in the US, with Fondazione Telethon holding the Biologics License Application (BLA). This would mark the first commercialization of a gene therapy via… Continue reading Fondazione Telethon and Orphan Therapeutics Accelerator Sign Memorandum of Understanding to Pioneer Non-Profit Commercial Access Model for Ultra-Rare Disease Gene Therapy in the US
Thompson Thrift to Develop Luxury Multifamily Community Outside Atlanta
ATLANTA, Dec. 15, 2025 /PRNewswire/ — Thompson Thrift, a full-service nationally recognized real estate company and one of the nation’s leading multifamily developers, today announced that it will develop Wrenly, a 214-unit multifamily community in the Atlanta suburb of Newnan. The company expects to welcome its first residents in April 2027, and construction completion is projected… Continue reading Thompson Thrift to Develop Luxury Multifamily Community Outside Atlanta
Housecall Pro releases new report highlighting changing customer service standards in home contracting
Survey shows homeowners choose Pros for digital convenience, AI-assisted communication and clear pricing—proving that customer experience now wins the job SAN DIEGO, Dec. 15, 2025 /PRNewswire/ — Housecall Pro, a leading software platform for home service professionals, announces the release of its new report, “The New Home Service Standard: How Systems, Not Just Skills, Win… Continue reading Housecall Pro releases new report highlighting changing customer service standards in home contracting
OpenAI Case Study Validates Podium’s AI Impact as Company Launches Jerry 2.0 for Automotive, HVAC, and Medspa
LEHI, Utah, Dec. 15, 2025 /PRNewswire/ — Podium, the leading AI conversion and communications platform for local businesses, announced the launch of Jerry 2.0, a significant leap forward in AI for the industries it serves (which include automotive, home services, and aesthetics). This release coincides with a new OpenAI case study which details how Podium leverages GPT-5.1 to create… Continue reading OpenAI Case Study Validates Podium’s AI Impact as Company Launches Jerry 2.0 for Automotive, HVAC, and Medspa
Vanda Announces Submission of Biologics License Application to the FDA for Imsidolimab for the Treatment of Generalized Pustular Psoriasis
WASHINGTON, Dec. 15, 2025 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for imsidolimab, a novel IgG4 IL-36 receptor antagonist, to treat generalized pustular psoriasis (GPP). Imsidolimab inhibits IL-36 receptor signaling, addressing the deficiency in the endogenous IL-36RA… Continue reading Vanda Announces Submission of Biologics License Application to the FDA for Imsidolimab for the Treatment of Generalized Pustular Psoriasis